Camena Bioscience

Provider of synthetic DNA

Camena has developed a wholly novel and proprietary enzymatic technology to accurately produce synthetic DNA. Unlike other enzymatic approaches, Camena does not use TdT, therefore overcoming the limitations inherent in this methodology.

  • Investment status Current
  • Invested 2023
  • Category Health & Life Sciences